Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Never forget to consider the number needed to treat

Hans Duvefelt, MD
Conditions
November 3, 2017
Share
Tweet
Share

How would you like to double your chances of winning the lottery? Just buy two tickets!

Statistically, this is true, but is that a reason to spend more money on something that most likely offers no return on investment?

Yet, in medical research, study after study shows impressive improvement in relative risk for this, that and the other intervention but a small or even negligible effect on absolute risk.

For example, I just read a study in the New England Journal of Medicine comparing giving a new osteoporosis drug to women with osteoporosis and a prior history of an osteoporotic fracture for one year, followed by an older drug for one year to just giving the older drug for two years. The two drug regimen lowered an osteoporotic woman’s risk of hip fracture by 38 percent.

The number of hip fractures in the combination treatment group was 41 out of 2046 patients, and in the single drug group, it was 66 out of 2047 patients.

In absolute numbers, treating 2046 patients reduced the hip fracture risk by 25 cases. The number of women one would need to treat to avoid one hip fracture, the number needed to treat (NNT), is 2046 divided by 25, or 81.

That NNT isn’t terribly impressive, especially in light of the fact that 12 more patients in the new drug group had a cardiovascular event in the first year than in the old drug group.

The editorial accompanying this article does say “In sum, ARCH revealed that romosozumab has great potential as a short-term anabolic treatment for osteoporosis. However, until the cardiovascular and endocrine effects of this antibody are clarified, romosozumab will remain more a part of our expectations than our armamentarium.” But if the drug company starts promoting the relative risk reduction of this treatment, doctors could be misled, and patients could come to harm.

Here are some more examples of he number needed to treat for some common health interventions, published in a post I wrote 7 years ago:

  1. Shingles vaccine doses given in order to avoid one case of shingles: 59
  2. Ear infections treated with amoxicillin to avoid one ruptured eardrum: 20
  3. Cortisone shots to relieve one sore shoulder: 3
  4. Aspirin prescriptions to prevent one heart attack: 200
  5. Prostate cancers treated in order to prevent one death: 18 to 48 (most men with prostate cancer don’t die from their disease)
  6. Adenomatous colon polyps removed to prevent one colon cancer: 50 (only 2 percent of “precancerous polyps” actually turn into cancer)

May I never forget to consider the NNT.

“A Country Doctor” is a family physician who blogs at A Country Doctor Writes:.

Image credit: Shutterstock.com

Prev

Freestanding ERs and retail clinics: Do they create a more efficient health care system?

November 3, 2017 Kevin 10
…
Next

One nurse for 4,000 pupils isn't the healthiest arrangement

November 3, 2017 Kevin 0
…

ADVERTISEMENT

Tagged as: Endocrinology

Post navigation

< Previous Post
Freestanding ERs and retail clinics: Do they create a more efficient health care system?
Next Post >
One nurse for 4,000 pupils isn't the healthiest arrangement

ADVERTISEMENT

More by Hans Duvefelt, MD

  • The art of asking where it hurts

    Hans Duvefelt, MD
  • Thinking like a plumber when adjusting medications

    Hans Duvefelt, MD
  • The American food conspiracy

    Hans Duvefelt, MD

Related Posts

  • Doctors: Never forget the importance of eye contact

    Suneel Dhand, MD
  • The CDC word ban: an attack on the patients I treat

    Rachel Alinsky, MD
  • To treat future COVID variants, we need more than vaccines

    Ian Chan, MBA
  • Using low-dose naltrexone to treat pain

    Alex Smith
  • The way we treat young doctors is barbaric

    David Penner
  • The scents in the hospital are from diseases you’ll never forget

    Yoo Jung Kim, MD

More in Conditions

  • How fNIRS and light therapy are shaping precision psychiatry

    Muhamad Aly Rifai, MD
  • The emotional labor of volunteering in an aging society

    Gerald Kuo
  • Understanding the evolutionary mismatch in health and modern disease

    Max Goodman, MD
  • Why Brooklyn’s aging population needs more vascular health specialists

    Anil Hingorani, MD
  • Why pediatricians are key to postpartum depression screening

    Mikenna Reiser
  • Prostate cancer genomic testing: a physician-patient’s perspective

    Francisco M. Torres, MD
  • Most Popular

  • Past Week

    • A physician father on the Dobbs decision and reproductive rights

      Travis Walker, MD, MPH | Physician
    • Putting health back into insurance: the case for tobacco cessation

      Edward Anselm, MD | Policy
    • What is the minority tax in medicine?

      Tharini Nagarkar and Maranda C. Ward, EdD, MPH | Education
    • Will AI replace primary care physicians?

      P. Dileep Kumar, MD, MBA | Tech
    • Why every physician needs a sabbatical (and how to take one)

      Christie Mulholland, MD | Physician
    • Retail health care vs. employer DPC: Preparing for 2026 policy shifts

      Dana Y. Lujan, MBA | Policy
  • Past 6 Months

    • Why patient trust in physicians is declining

      Mansi Kotwal, MD, MPH | Physician
    • How environmental justice and health disparities connect to climate change

      Kaitlynn Esemaya, Alexis Thompson, Annique McLune, and Anamaria Ancheta | Policy
    • A physician father on the Dobbs decision and reproductive rights

      Travis Walker, MD, MPH | Physician
    • The blind men and the elephant: a parable for modern pain management

      Richard A. Lawhern, PhD | Conditions
    • Is tramadol really ineffective and risky?

      John A. Bumpus, PhD | Meds
    • Why insurance must cover home blood pressure monitors

      Soneesh Kothagundla | Conditions
  • Recent Posts

    • How fNIRS and light therapy are shaping precision psychiatry

      Muhamad Aly Rifai, MD | Conditions
    • Difficult patients in medical history

      Joan Naidorf, DO | Physician
    • The emotional labor of volunteering in an aging society

      Gerald Kuo | Conditions
    • Understanding the evolutionary mismatch in health and modern disease

      Max Goodman, MD | Conditions
    • Silence is a survival mechanism that costs women their joy [PODCAST]

      The Podcast by KevinMD | Podcast
    • FDA loosens AI oversight: What clinicians need to know about the 2026 guidance

      Arthur Lazarus, MD, MBA | Policy

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 7 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • A physician father on the Dobbs decision and reproductive rights

      Travis Walker, MD, MPH | Physician
    • Putting health back into insurance: the case for tobacco cessation

      Edward Anselm, MD | Policy
    • What is the minority tax in medicine?

      Tharini Nagarkar and Maranda C. Ward, EdD, MPH | Education
    • Will AI replace primary care physicians?

      P. Dileep Kumar, MD, MBA | Tech
    • Why every physician needs a sabbatical (and how to take one)

      Christie Mulholland, MD | Physician
    • Retail health care vs. employer DPC: Preparing for 2026 policy shifts

      Dana Y. Lujan, MBA | Policy
  • Past 6 Months

    • Why patient trust in physicians is declining

      Mansi Kotwal, MD, MPH | Physician
    • How environmental justice and health disparities connect to climate change

      Kaitlynn Esemaya, Alexis Thompson, Annique McLune, and Anamaria Ancheta | Policy
    • A physician father on the Dobbs decision and reproductive rights

      Travis Walker, MD, MPH | Physician
    • The blind men and the elephant: a parable for modern pain management

      Richard A. Lawhern, PhD | Conditions
    • Is tramadol really ineffective and risky?

      John A. Bumpus, PhD | Meds
    • Why insurance must cover home blood pressure monitors

      Soneesh Kothagundla | Conditions
  • Recent Posts

    • How fNIRS and light therapy are shaping precision psychiatry

      Muhamad Aly Rifai, MD | Conditions
    • Difficult patients in medical history

      Joan Naidorf, DO | Physician
    • The emotional labor of volunteering in an aging society

      Gerald Kuo | Conditions
    • Understanding the evolutionary mismatch in health and modern disease

      Max Goodman, MD | Conditions
    • Silence is a survival mechanism that costs women their joy [PODCAST]

      The Podcast by KevinMD | Podcast
    • FDA loosens AI oversight: What clinicians need to know about the 2026 guidance

      Arthur Lazarus, MD, MBA | Policy

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Never forget to consider the number needed to treat
7 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...